These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy. Shindo M, Arai K, Sokawa Y, Okuno T. Ann Intern Med; 1995 Apr 15; 122(8):586-91. PubMed ID: 7887552 [Abstract] [Full Text] [Related]
6. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A. J Med Virol; 1995 Nov 15; 47(3):285-91. PubMed ID: 8551282 [Abstract] [Full Text] [Related]
10. Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment. Yun ZB, Reichard O, Chen M, Lundeberg J, Norkrans G, Fryden A, Sönnerborg A, Weiland O. Scand J Infect Dis; 1994 Nov 15; 26(3):263-70. PubMed ID: 7939425 [Abstract] [Full Text] [Related]
11. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up. Diodati G, Bonetti P, Tagger A, Casarin C, Noventa F, Ribero M, Fasola M, Ruol A, Realdi G. Dig Dis Sci; 1994 Nov 15; 39(11):2497-502. PubMed ID: 7525169 [Abstract] [Full Text] [Related]
12. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Marcellin P, Descamps V, Martinot-Peignoux M, Larzul D, Xu L, Boyer N, Pham BN, Crickx B, Guillevin L, Belaich S. Gastroenterology; 1993 Jan 15; 104(1):272-7. PubMed ID: 8380394 [Abstract] [Full Text] [Related]
13. Case report: bilateral Mooren ulcer in association with hepatitis C. Aaltonen V, Alavesa M, Pirilä L, Vesti E, Al-Juhaish M. BMC Ophthalmol; 2017 Dec 06; 17(1):239. PubMed ID: 29212473 [Abstract] [Full Text] [Related]
14. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G. N Engl J Med; 1994 Mar 17; 330(11):751-6. PubMed ID: 8107741 [Abstract] [Full Text] [Related]
15. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells. Kusaka S, Okusa T, Araki A, Fujiki K, Takashimizu I, Okayasu I, Yamamoto N, Sato C. J Med Virol; 1995 Jul 17; 46(3):265-8. PubMed ID: 7561801 [Abstract] [Full Text] [Related]
16. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration. Saitoh Y, Miura M, Niitsuma H, Numata N, Ohori H, Ishii M, Toyota T. Tohoku J Exp Med; 1994 Aug 17; 173(4):361-9. PubMed ID: 7529950 [Abstract] [Full Text] [Related]
17. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA. Cho HJ, Dong SH, Lee MS, Kim HY, Park CK, Yoo JY, Polito A, Quan S, Han JH. Korean J Intern Med; 1992 Jan 17; 7(1):13-7. PubMed ID: 1282364 [Abstract] [Full Text] [Related]
18. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course. Reichard O, Glaumann H, Norkrans G, Wejstål R, Fryden A, Schvarcz R, Weiland O. Liver; 1994 Aug 17; 14(4):169-74. PubMed ID: 7526108 [Abstract] [Full Text] [Related]
19. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S. Ann Intern Med; 1997 Nov 15; 127(10):875-81. PubMed ID: 9382365 [Abstract] [Full Text] [Related]
20. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escartín P. J Hepatol; 1996 Mar 15; 24(3):308-12. PubMed ID: 8778197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]